CYP19A1 and prostate neoplasm: In this sense we found that CYP19A1 was present in the CTC population of our mCRPC patients suggesting that patients progressing after androgen deprivation could present adaptative mechanisms to maintain the hormone stimulation of prostate tumor cells.